文献速递泌尿生殖与妇科肿瘤放疗放疗物理与技术

前列腺癌立体定向体部放疗中水凝胶间隔物注射与治疗计划之间所需的最短间隔

Minimum Required Interval Between Hydrogel Spacer Injection and Treatment Planning for Stereotactic Body Radiation Therapy for Prostate Cancer.
PubMed 文献 · Pract Radiat Oncol · 2022-02-07

本研究回顾性分析了15例接受CyberKnife立体定向体部放疗(36.25 Gy/5次)的前列腺癌患者,比较水凝胶间隔物注射后CT模拟定位日与末次治疗日的磁共振图像。结果显示两次图像间间隔物体积差异有统计学意义但平均差异小于1 cm³,形状相似性平均Dice系数大于0.83,体积变化与注射至CT模拟定位的间隔无明确相关性。结论认为注射后1天作为间隔物注射与治疗计划之间的间隔是可接受的。

要点

  • 水凝胶间隔物注射与CT模拟定位的中位间隔为1天(范围1-9天)。
  • CT模拟定位至末次治疗的中位间隔为17天(范围14-25天)。
  • 两次磁共振图像间间隔物体积差异有统计学意义,但平均差异小于1 cm³。

核心结论

  • 对于前列腺癌立体定向体部放疗,水凝胶间隔物注射与治疗计划之间1天的间隔是可接受的。

研究设计与样本

  • 回顾性研究纳入15例接受CyberKnife系统立体定向体部放疗(36.25 Gy/5次)的前列腺癌患者。
  • 在水凝胶间隔物注射后获取两次磁共振图像:CT模拟定位日(治疗前磁共振,MRpre)和末次治疗日(治疗后磁共振,MRpost)。
  • 由两名医学物理师在每张磁共振图像上勾画水凝胶间隔物,评估两次图像间间隔物形状和体积的变化。

主要发现

  • 水凝胶间隔物注射与CT模拟定位的中位间隔为1天(范围1-9天)。
  • CT模拟定位与末次治疗的中位间隔为17天(范围14-25天)。
  • 两名观察者均观察到MRpre与MRpost之间水凝胶间隔物体积存在显著差异,但平均体积差异小于1 cm³。
  • MRpre与MRpost之间形状比较的平均Dice相似系数大于0.83。
  • 体积变化与从水凝胶间隔物注射至CT模拟定位的间隔之间未确认有明确相关性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The present study evaluated the short-term characteristics (<3 days) of a hydrogel spacer from the time of injection during stereotactic body radiation therapy (SBRT) for prostate cancer. METHODS AND MATERIALS: Fifteen patients treated with SBRT via the CyberKnife system (36.25 Gy/5 fractions) were enrolled in this retrospective study. Two magnetic resonance (MR) images were obtained with a hydrogel spacer: one on a computed tomography (CT) simulation day (MR pretreatment [MRpre]) and the other on the last treatment day (MR posttreatment [MRpost]). Two medical physicists contoured the hydrogel spacer on each MR image. The changes of the shapes and the volume for the hydrogel spacer between 2 MR images were evaluated. RESULTS: The median period between hydrogel spacer injection and CT simulation was 1 day (range, 1-9 days). The median period between CT simulation and the last treatment was 17 days (range, 14-25 days). Regarding the volume change of the hydrogel spacer, the 2 observers observed significant differences between the volumes of the hydrogel spacer on the MRpre and MRpost. However, the average volume difference between them was less than 1 cm3. The average dice similarity coefficient between the MRpre and MRpost to compare the shape was more than 0.83. In addition, no clear correlation was confirmed between the volume change and the period from hydrogel spacer injection to CT simulation. CONCLUSIONS: A single day is an acceptable interval between hydrogel spacer injection and treatment planning for SBRT for prostate cancer.

来源:Pract Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Saito M, Suzuki T, Suzuki H, et al. Minimum Required Interval Between Hydrogel Spacer Injection and Treatment Planning for Stereotactic Body Radiation Therapy for Prostate Cancer. Pract Radiat Oncol. 2022. PMID: 35144015. doi:10.1016/j.prro.2022.01.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。